The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
March 28th 2024
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Most Eligible Patients With Diabetic Kidney Disease Not Receiving SGLT2 Inhibitor Prescriptions
May 17th 2021Two-thirds of patients with diabetic kidney disease who are eligible for treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors are not being prescribed them, a new study shows.
Read More
Analysis Looks at SGLT2 Inhibitors Across Diabetes, Heart Failure, CKD
May 14th 2021Sodium-glucose transporter 2 (SGLT2) inhibitors decrease the risk of acute kidney injury and severe hypoglycemia for those with diabetes, heart failure, and chronic kidney disease (CKD) but increase the risk of diabetic ketoacidosis.
Read More
Dropping Race From eGFR Doubles Estimated Prevalence of CKD in Black Populations
May 6th 2021The study results were released as nephrologists and others are awaiting the findings of a joint task force of 2 national kidney organizations looking at alternative approaches to estimating glomerular filtration rate.
Read More
FDA Approves Oral Dapagliflozin to Slow Kidney Decline
April 30th 2021Last year, a data monitoring committee halted the DAPA-CKD trial when it found the evidence of efficacy was overwhelming, after it was shown the trial met all its primary and secondary end points for patients with chronic kidney disease, with and without type 2 diabetes.
Read More
Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds
March 18th 2021The study examined the cost to Medicare when patients with end-stage renal disease switched from their employer-based health insurance to Medicare between 2007 and 2017 before the end of the 30-month coordination period.
Read More
Study Describes AKI Incidence in Children With COVID-19, MIS-C
March 6th 2021A retrospective study looking at pediatric patients hospitalized in 4 New York hospitals in 2020 with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) found that acute kidney injury (AKI) occurred in 11.8% of patients.
Read More
Kidney Transplants Benefit Patients With SCD, But Few Have Chance to Receive Them
March 5th 2021Despite benefitting from organ transplants similarly to other patients with kidney failure, a new study found patients with kidney failure associated with sickle cell disease (SCD) are less likely to receive transplants.
Read More
Genetic Picture Emerges of Polycystic Kidney Disease in Ireland
February 27th 2021Cutting-edge genetic tools diagnosed 83% of Irish patients with polycystic kidney disease (PKD), identified 36 novel variants, and discovered that seemingly unrelated individuals with the same variant likely inherited it from a common ancestor.
Read More